Skip to main content
Log in

Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges


  • main topic
  • Published:
Wiener Medizinische Wochenschrift Aims and scope Submit manuscript

Summary

Acral lentiginous melanoma (ALM) is an uncommon melanoma type among Caucasions. ALM bears an unfavorable prognosis because of late presentation or common misdiagnosis. Amelanotic variants, albeit rare, may pose an additional clinical challenge and may further delay the diagnosis and treatment. Thus, the threshold for biopsying even marginally suspicious lesions should be low. We present two cases of Caucasian patients with amelanotic subungual ALM, stage 2a and 2c respectively, successfully treated with a functional amputation.

Zusammenfassung

Das akolentiginöse Melanom (ALM) ist unter Kaukasiern eher selten. ALM ist mit einer ungünstigen Prognose verknüpft infolge verzögerter Diagnose und von Fehldiagnosen. Seine amelanotische Variante ist selten, führt jedoch häufiger zu weiterer diagnostischer Verzögerung. Deshalb sollten verdächtige Läsionen frühzeitig bioptiert werden. Wir stellen 2 Patienten mit amelanotischem ALM, Stadium 2a und 2c, vor, die mittels funktioneller Amputation erfolgreich behandelt wurden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Ridgeway C, Hieken T, Ronan S, et al. Acral lentiginous melanoma. Arch Surg. 1995;130:88–92.

    Article  PubMed  CAS  Google Scholar 

  2. Finlay RK III, Driscoll DL, Blumenson LE, Karakousis CP. Subungual melanoma: an eighteen-year review. Surgery. 1994;116:96–100.

    Google Scholar 

  3. Wouters LT, Thissen MR. The acrolentiginous melanoma: how to recognize and when to refer?. Ned Tijdschr Geneeskd. 2012;156(34):A4927.

    PubMed  Google Scholar 

  4. Koch SE, Lange JR. Amelanotic melanoma: the great masquerader. J Am Acad Dermatol. 2000;45:731–4.

    Article  Google Scholar 

  5. Banfield CC, Redburn JC, Dawber RPR. The incidence and prognosis of nail apparatus melanoma. A retrospective study of 105 patients in four English regions. Br J Dermatol. 1998;139:276–9.

    Article  PubMed  CAS  Google Scholar 

  6. Kato T, Suetake T, Sugiyama Y, Tabata N, Tagami H. Epidemiology and prognosis of subungual melanoma in 34 Japanese patients. Br J Dermatol. 1996;134:383–7.

    Article  PubMed  CAS  Google Scholar 

  7. Sureda N, Phan A, Poulalhon N, Balme B, Dalle S, Thomas L. Conservative surgical management of subungual (matrix derived) melanoma: report of seven cases and literature review. Br J Dermatol. 2011;165:852–8.

    Article  PubMed  CAS  Google Scholar 

  8. Haneke E. Ungual melanoma—controversies in diagnosis and treatment. Dermatol Ther. 2012;25:510–24.

    Article  PubMed  Google Scholar 

  9. Rex J, Paradelo C, Mangas C, Hilari JM, Fernandez-Figueras MT, Ferrandiz C. Management of primary cutaneous malignant melanoma of the hands and feet: a clinicoprognostic study. Dermatol Surg. 2009;35:1505–13.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest


The authors have no financial interest in this manuscript and no affiliations (relationship) to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uwe Wollina MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guarneri, C., Bevelacqua, V., Semkova, K. et al. Subungual acrolentiginous amelanotic melanoma treated with amputation of the distal and middle phalanges
. Wien Med Wochenschr 163, 368–371 (2013). https://doi.org/10.1007/s10354-013-0194-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10354-013-0194-4

Keywords

Schlüsselwörter

Navigation